ABSTRACT
Magnetic resonance images (MRI) of the brain exhibit high dimensionality that pose significant challenges for computational analysis. While models proposed for brain MRIs analyses yield encouraging results, the high complexity of neuroimaging data hinders generalizability and clinical application. We introduce DUNE, a neuroimaging-oriented encoder designed to extract deep-features from multisequence brain MRIs, thereby enabling their processing by basic machine learning algorithms. A UNet-based autoencoder was trained using 3,814 selected scans of morphologically normal (healthy volunteers) or abnormal (glioma patients) brains, to generate comprehensive low-dimensional representations of the full-sized images. To evaluate their quality, these embeddings were utilized to train machine learning models to predict a wide range of clinical variables. Embeddings were extracted for cohorts used for the model development (n=21,102 individuals), along with 3 additional independent cohorts (Alzheimer’s disease, schizophrenia and glioma cohorts, n=1,322 individuals), to evaluate the model’s generalization capabilities. The embeddings extracted from healthy volunteers’ scans could predict a broad spectrum of clinical parameters, including volumetry metrics, cardiovascular disease (AUROC=0.80) and alcohol consumption (AUROC=0.99), and more nuanced parameters such as the Alzheimer’s predisposing APOE4 allele (AUROC=0.67). Embeddings derived from the validation cohorts successfully predicted the diagnoses of Alzheimer’s dementia (AUROC=0.92) and schizophrenia (AUROC=0.64). Embeddings extracted from glioma scans successfully predicted survival (C-index=0.608) and IDH molecular status (AUROC=0.92), matching the performances of previous task-oriented models. DUNE efficiently represents clinically relevant patterns from full-size brain MRI scans across several disease areas, opening ways for innovative clinical applications in neurology.
One Sentence Summary We propose a brain MRI-specialized encoder, which extracts versatile low-dimension embeddings from full-size scans.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
TCGA database ADNI database SchizConnect database UK Biobank database
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
The source codes of the different autoencoders presented in this manuscript are available on GitHub at https://github.com/gevaertlab/BrainMR_AE_datafusion.
